Urogen Pharma Ltd (URGN)

Operating Cash Flow Growth

-29.06%

TTM · Period ending:

URGN logo

URGN Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-29.06%
URGN TTM Cash from Operations YoY % (160.31% → -29.06%)
High-resolution chart · PNG

URGN operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Urogen Pharma Ltd Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-29.0623%
-54.8139%
-67.873%
-43.1744%
-43.447%
-29.978%
-26.5975%
-13.0045%
-1.5437%
6.8892%
11.7847%
-0.1965%
2.5455%
-8.5548%
-2.0674%
1.2769%
6.396%
16.5537%
19.827%
22.2154%
5.5295%
-10.0701%
-49.0995%
-100.0759%
-88.45%
-94.3695%
-90.2207%
-67.5179%
-146.2718%
-177.4711%
-290.0742%
-439.0367%
-684.8367%
-503.681%
-328.4794%
191.2046%
142.6129%
160.3078%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.